How government-dependent is SAREPTA THERAPEUTICS, INC.?

In fiscal year 2025, US federal contract obligations equal at least 0.0% of SAREPTA THERAPEUTICS, INC.'s reported revenue - $0 in federal awards against $1.9B in revenue as filed with the SEC. In fiscal year 2024 the share was at least 0.0%.

Cite as: FACTANKER, https://factanker.com/entity/203e771e-2905-4b94-97fb-3e2bf6eebd1f/government-dependency

Fiscal yearRevenue (SEC, as filed)Federal obligationsShareData status
FY 2025$1.9B$0≥ 0.0%contracts only
FY 2024$1.8B$0≥ 0.0%contracts only
Evidence
Revenue FY 2025: evidence fact 16545497… (SEC filing)
Federal obligations FY 2025: sum of 1 award records (USAspending bulk data)
Identity consolidation: CIK 0000873303 · LEI 549300IKDPIED8J8IG21 · UEI FVMHHCGQKM83 - linked via evidence-backed same_as facts, see all facts of this organization
Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).
Not claimed

SAREPTA THERAPEUTICS, INC. - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart